87 related articles for article (PubMed ID: 280704)
1. Effectiveness of glucan in the treatment of human neoplasia.
Proctor JW; Yamamura Y
J Natl Cancer Inst; 1978 Nov; 61(5):1179-80. PubMed ID: 280704
[No Abstract] [Full Text] [Related]
2. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
Cheung NK; Modak S; Vickers A; Knuckles B
Cancer Immunol Immunother; 2002 Nov; 51(10):557-64. PubMed ID: 12384807
[TBL] [Abstract][Full Text] [Related]
3. Glucan immunotherapy as adjunct in the surgical excision of experimental melanoma.
Browder W; McNamee R; Di Luzio N
Surg Forum; 1977; 28():171-3. PubMed ID: 617407
[No Abstract] [Full Text] [Related]
4. Glucan:inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models.
Di Luzio NR; McNamee R; Browder WI; Williams D
Cancer Treat Rep; 1978 Nov; 62(11):1857-66. PubMed ID: 728903
[No Abstract] [Full Text] [Related]
5. Glucans as New Anticancer Agents.
Sima P; Richter J; Vetvicka V
Anticancer Res; 2019 Jul; 39(7):3373-3378. PubMed ID: 31262858
[TBL] [Abstract][Full Text] [Related]
6. Anthrax-protective effects of yeast beta 1,3 glucans.
Kournikakis B; Mandeville R; Brousseau P; Ostroff G
MedGenMed; 2003 Mar; 5(1):1. PubMed ID: 12827062
[TBL] [Abstract][Full Text] [Related]
7. Combination Therapy with Glucan and Coenzyme Q
Vetvicka V; Vetvickova J
Anticancer Res; 2018 Jun; 38(6):3291-3297. PubMed ID: 29848676
[TBL] [Abstract][Full Text] [Related]
8. BRD-glucan exhibits potent immunochemotherapeutic activity in vitro and in vivo.
Moon SH; Heo JC; Fine RL; Kim HM; Kim SU; Yoon BD; Lee SH
Int J Oncol; 2005 Feb; 26(2):395-404. PubMed ID: 15645124
[TBL] [Abstract][Full Text] [Related]
9. Orally administered beta-1,6-D-polyglucose extracted from Agaricus blazei results in tumor regression in tumor-bearing mice.
Oshiman K; Fujimiya Y; Ebina T; Suzuki I; Noji M
Planta Med; 2002 Jul; 68(7):610-4. PubMed ID: 12142994
[TBL] [Abstract][Full Text] [Related]
10. Can maitake MD-fraction aid cancer patients?
Kodama N; Komuta K; Nanba H
Altern Med Rev; 2002 Jun; 7(3):236-9. PubMed ID: 12126464
[TBL] [Abstract][Full Text] [Related]
11. Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failure.
Griswold DP; Corbett TH; Schabel FM
Cancer Treat Rep; 1981; 65 Suppl 2():51-4. PubMed ID: 7346146
[No Abstract] [Full Text] [Related]
12. Lysozyme activity: an index of macrophage functional status.
di Luzio NR
Front Biol; 1979; 48():447-62. PubMed ID: 387464
[No Abstract] [Full Text] [Related]
13. Pulmonary metastases neutralization and tumor rejection by in vivo administration of beta glucan and bispecific antibody.
Penna C; Dean PA; Nelson H
Int J Cancer; 1996 Jan; 65(3):377-82. PubMed ID: 8575861
[TBL] [Abstract][Full Text] [Related]
14. [Effect of beta-1,3 glucan and other immunomodulators of microbial origin on experimental leprosy in mice].
Rayyan W; Delville J
Acta Leprol; 1983; 1(2):93-100. PubMed ID: 6356766
[TBL] [Abstract][Full Text] [Related]
15. Active non-specific immunotherapy of experimental tumours.
Silobrcić V
Folia Biol (Praha); 1980; 26(3):145-66. PubMed ID: 6998756
[No Abstract] [Full Text] [Related]
16. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
[TBL] [Abstract][Full Text] [Related]
17. [Antineoplastic activity of L-asparaginase].
Grgić Z
Lijec Vjesn; 1969 Jul; 91(7):783-6. PubMed ID: 4910066
[No Abstract] [Full Text] [Related]
18. Antitumor activity of beta-D-glucan from Libyan dates.
Ishurd O; Zgheel F; Kermagi A; Flefla M; Elmabruk M
J Med Food; 2004; 7(2):252-5. PubMed ID: 15298775
[TBL] [Abstract][Full Text] [Related]
19. The effect of glucan--a host resistance activator--and ampicillin on experimental intraabdominal sepsis.
Lahnborg G; Hedström KG; Nord CE
J Reticuloendothel Soc; 1982 Nov; 32(5):347-53. PubMed ID: 7161767
[TBL] [Abstract][Full Text] [Related]
20. [Principles of adjuvant cytostatic therapy].
Schreml W
Aktuelle Probl Chir Orthop; 1982; 22():10-7. PubMed ID: 6121507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
